UY31107A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS. - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS.

Info

Publication number
UY31107A1
UY31107A1 UY31107A UY31107A UY31107A1 UY 31107 A1 UY31107 A1 UY 31107A1 UY 31107 A UY31107 A UY 31107A UY 31107 A UY31107 A UY 31107A UY 31107 A1 UY31107 A1 UY 31107A1
Authority
UY
Uruguay
Prior art keywords
treatment
agent
pharmaceutical composition
combination
urinary infections
Prior art date
Application number
UY31107A
Other languages
Spanish (es)
Inventor
Victor Guillermo Alvarez Ochoa
Josefina Santos Murillo
Maria Elena Garcia Armenta
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Priority to UY31107A priority Critical patent/UY31107A1/en
Publication of UY31107A1 publication Critical patent/UY31107A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a una composicion farmacéutica compuesta por la combinacion sinérgica de un agente antimicrobiano, conocido como: Ciprofloxacino y un agente antioxidante, tal como:Acido Ascorbico (Vitamina C), además de excipientes farmacéuticamente adeptables, mismos que se encuentran formulados en una sola unidad de dosis para ser administrada por vía oral, utilizada para el tratamiento de Infecciones urinarias, la cual proporciona un mayor efecto terapéutico, un incremento en el apego por el tratamiento y la reduccion de la infeccion en menor tiempo.The present invention relates to a pharmaceutical composition composed of the synergistic combination of an antimicrobial agent, known as: Ciprofloxacin and an antioxidant agent, such as: Ascorbic Acid (Vitamin C), in addition to pharmaceutically suitable excipients, which are formulated in a single dose unit to be administered orally, used for the treatment of urinary infections, which provides a greater therapeutic effect, an increase in the attachment for the treatment and the reduction of the infection in less time.

UY31107A 2008-05-27 2008-05-27 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS. UY31107A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY31107A UY31107A1 (en) 2008-05-27 2008-05-27 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY31107A UY31107A1 (en) 2008-05-27 2008-05-27 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS.

Publications (1)

Publication Number Publication Date
UY31107A1 true UY31107A1 (en) 2008-11-28

Family

ID=40336328

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31107A UY31107A1 (en) 2008-05-27 2008-05-27 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS.

Country Status (1)

Country Link
UY (1) UY31107A1 (en)

Similar Documents

Publication Publication Date Title
ECSP078023A (en) ACTIVE PHARMACEUTICAL INGREDIENT BASED ON CANABINOID
NZ604029A (en) Methods of treating bladder cancer
AR048705A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
MD4577C1 (en) Chewable veterinary compositions comprising an isoxazoline active agent and their use in the treatment and/or prophylaxis of a parasitic infection and infestation
MX2014002171A (en) Combination treatments for hepatitis c.
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
CR11724A (en) AGENT TO TREAT DISEASES
MX2010009623A (en) 1-benzyl-3-hydroxymethylindazoiî¹e derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1.
MX2010009625A (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40.
MX2010009624A (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1.
HRP20192189T1 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
CL2019002172A1 (en) Therapeutic agent for liver diseases.
CO2019004004A2 (en) Pharmaceutical composition and method for the treatment of non-alcoholic fatty liver disease
CO6640318A2 (en) Oral dosage forms of bendamustine
UY30847A1 (en) USE OF DIANHYDROHEXITE MONONITRATE DERIVATIVES AS AGENTS FOR THE TREATMENT OF INTESTINAL DISORDERS
PE20130147A1 (en) PHARMACEUTICAL COMBINATION OF THEOBROMINE AND A NON-OPIOID ANTITUSSIVE AGENT
AR066666A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
AR075866A1 (en) A DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL DETERIORATION. USE. PHARMACEUTICAL COMPOSITION
ECSP099733A (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF THE CIPROFLOXACINE ANTIMICROBIAL AGENT AND THE ASCORBIC ACID ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTION
RU2013105513A (en) Derivatives of 1-aminoalkylcyclohexane for the treatment of inflammatory skin diseases
PE20130308A1 (en) METHODS TO TREAT RECURRING BACTERIAL INFECTIONS
AR074246A1 (en) DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF SOIL DISORDERS
UY31107A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS.
UY33468A (en) THERAPEUTIC AGENT OF SUSTAINED LIBERATION FOR HYPERTENSION AND RENAL DYSFUNCTION